Por favor, use este identificador para citar o enlazar este ítem:
http://conacyt.repositorioinstitucional.mx/jspui/handle/1000/7545
Evaluation of the Cepheid Xpert Xpress SARS-CoV-2 test for bronchoalveolar lavage | |
Tung Phan Ashley Mays Melissa McCullough Alan Wells | |
Acceso Abierto | |
Atribución-SinDerivadas | |
https://doi.org/10.1101/2021.12.21.21268190 | |
https://www.medrxiv.org/content/10.1101/2021.12.21.21268190v1 | |
Accurate and rapid laboratory tests are essential for the prompt diagnosis of COVID-19, which is important to patients and infection control. The Xpert Xpress SARS-CoV-2 test is a real-time RT-PCR intended for the qualitative detection of nucleic acid from SARS-CoV-2 in upper respiratory specimens. In this study, we assessed the analytical and clinical performance characteristics of this rapid test for SARS-CoV-2 in 60 bronchoalveolar lavage (BAL) specimens. BAL is a specimen type that is not authorized under EUA for the Xpert Xpress SARS-CoV-2 test. The limit of detection of the Xpert Xpress SARS-CoV-2 test was 500 copies/ml. The overall agreement of the Xpert Xpress SARS-CoV-2 test was 100%. The Xpert Xpress SARS-CoV-2 test is sensitive and specific to aid in diagnosis of COVID-19 using bronchoalveolar lavage. | |
medRxiv and bioRxiv | |
30-12-2021 | |
Preimpreso | |
www.medrxiv.org | |
Inglés | |
Epidemia COVID-19 | |
Público en general | |
VIRUS RESPIRATORIOS | |
Versión publicada | |
publishedVersion - Versión publicada | |
Aparece en las colecciones: | Artículos científicos |
Cargar archivos:
Fichero | Tamaño | Formato | |
---|---|---|---|
Evaluation of the Cepheid Xpert Xpress SARS COV2 test for bronchoalveolar lavage.pdf | 50.52 kB | Adobe PDF | Visualizar/Abrir |